Rankings
▼
Calendar
AKBA Q3 2017 Earnings — Akebia Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
AKBA
Akebia Therapeutics, Inc.
$366M
Q3 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$41M
Gross Profit
-$17M
-42.2% margin
Operating Income
-$24M
-58.6% margin
Net Income
-$23M
-56.0% margin
EPS (Diluted)
$-0.49
QoQ Revenue Growth
+44.8%
Cash Flow
Operating Cash Flow
-$55M
Free Cash Flow
-$55M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$339M
Total Liabilities
$239M
Stockholders' Equity
$100M
Cash & Equivalents
$90M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$41M
$0
—
Gross Profit
-$17M
-$31M
+44.2%
Operating Income
-$24M
-$36M
+33.2%
Net Income
-$23M
-$36M
+36.3%
← FY 2017
All Quarters
Q4 2017 →